DNA REPAIR POLYMORPHISMS AND SPORADIC BREAST CANCER
DNA 修复多态性与散发性乳腺癌
基本信息
- 批准号:6378000
- 负责人:
- 金额:$ 12.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Applicant's Description)
Several cancers are known to arise from genetic defects in DNA repair genes.
We propose to test whether concurrent germline defects in base-excision DNA
repair genes are associated with sporadic breast cancer. Our focus is on small
genetic variations we call eSNPs, exon Single Nucleotide Polymorphisms, in the
coding region and the flanking control regions in the exons of genes. Specific
Aim 1 is to screen the germline DNA of hundreds of women, half with sporadic
breast cancer, for the presence of eSNPs in base-excision repair genes, and to
test for the association of these eSNPs with breast cancer. In Specific Aim 2,
we propose to develop a novel methodology that can be used to rapidly screen
for eSNPs in these genes in thousands of individuals. In base-excision repair,
more than one enzyme is specific for a given DNA damage. We hypothesize that
when deleterious germline eSNPs occur concurrently in different genes of
base-excision repair enzymes, the repair efficiency would decrease and somatic
mutation rates would rise, and lead to cancer. Breast cancer that originates
from multiple germline defects may seem to be sporadic. Currently it is
impractical to screen for eSNPs in tens of repair genes in thousands of
individuals. Initially, we will focus on the T/G mismatch that arises from
spontaneous deamination of 5-methyl-cytosine residues in the DNA. Seven
base-excision repair genes that correct this mismatch will be screened for
eSNPs. The genes are: TDG, MEDI (MBD4), APE, NTHLI, PCNA, FEN1, and POL . The
eSNP detection method we will use is based on a mismatch-specific CEL I
nuclease we discovered. We propose to use a new mismatch-specific property of
CEL I to perform affinity selection of total eSNPs, and also to enable
affinity subtraction to remove the common alleles of eSNPs. The end product
will be a highly emiched eSNP collection specific for sporadic breast cancer.
Our proposed procedure will lead to a complete database of common and rare
eSNPs in these genes so that existing technologies can do mass genotyping
studies.
描述:(申请人的描述)
已知几种癌症是由DNA修复基因的遗传缺陷引起的。
我们建议测试是否并发生殖缺陷的碱基切除DNA
修复基因与散发性乳腺癌有关。我们的重点是小
基因变异,我们称之为eSNPs,外显子单核苷酸多态性,在
基因外显子中的编码区和侧翼控制区。具体
目标1是筛选数百名女性的生殖系DNA,其中一半患有散发性乳腺癌。
乳腺癌,碱基切除修复基因中存在eSNP,以及
检测这些eSNPs与乳腺癌的关联。在具体目标2中,
我们建议开发一种新的方法,
这些基因中的eSNPs。在碱基切除修复中,
不止一种酶对给定的DNA损伤具有特异性。我们假设
当有害的生殖系eSNPs同时出现在不同的基因中时,
碱基切除修复酶,修复效率会降低,
突变率会上升,并导致癌症乳腺癌起源于
多个生殖系缺陷引起的疾病似乎是偶发的。目前它是
在成千上万的人中筛选数十个修复基因中的eSNP是不切实际的,
个体首先,我们将重点关注T/G失配,
DNA中5-甲基-胞嘧啶残基的自发脱氨。七
将筛选纠正这种错配的碱基切除修复基因,
eSNPs。这些基因是:TDG、MEDI(MBD 4)、APE、NTHLI、PCNA、FEN 1和POL。的
我们将使用的eSNP检测方法是基于错配特异性CEL I
我们发现的核酸酶。 我们建议使用一个新的特定于失配的属性:
CEL I以执行总eSNP的亲和力选择,并且还使
亲和力减法以去除eSNP的共同等位基因。最终产品
将是散发性乳腺癌特异性的高度富集的eSNP集合。
我们提出的程序将导致一个完整的数据库,共同和罕见的
这些基因中的eSNPs,以便现有技术可以进行大规模基因分型
问题研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY T YEUNG其他文献
ANTHONY T YEUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY T YEUNG', 18)}}的其他基金
Proteomic Validation of the Min Mouse Model of Colon Cancer
结肠癌小鼠模型的蛋白质组学验证
- 批准号:
7215018 - 财政年份:2006
- 资助金额:
$ 12.61万 - 项目类别:
Proteomic Validation of the Min Mouse Model of Colon Cancer
结肠癌小鼠模型的蛋白质组学验证
- 批准号:
7289221 - 财政年份:2006
- 资助金额:
$ 12.61万 - 项目类别:
Proteomic Biomarkers in Pancreatic Cyst Fluids
胰腺囊肿液中的蛋白质组生物标志物
- 批准号:
7125950 - 财政年份:2005
- 资助金额:
$ 12.61万 - 项目类别:
Proteomic Biomarkers in Pancreatic Cyst Fluids
胰腺囊肿液中的蛋白质组生物标志物
- 批准号:
7036308 - 财政年份:2005
- 资助金额:
$ 12.61万 - 项目类别:
DNA REPAIR POLYMORPHISMS AND SPORADIC BREAST CANCER
DNA 修复多态性与散发性乳腺癌
- 批准号:
6166746 - 财政年份:2000
- 资助金额:
$ 12.61万 - 项目类别:
相似海外基金
Pathology of Breast Neoplasms determined by MRS
MRS 测定乳腺肿瘤的病理学
- 批准号:
nhmrc : 950215 - 财政年份:1995
- 资助金额:
$ 12.61万 - 项目类别:
NHMRC Project Grants